“Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data” (2022) SKIN The Journal of Cutaneous Medicine, 6(2), p. s12. doi:10.25251/skin.6.supp.12.